The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
View ORCID ProfileGabriel Chodick, Lilac Tene, Tal Patalon, Sivan Gazit, Amir Ben Tov, Dani Cohen, View ORCID ProfileKhitam Muhsen
doi: https://doi.org/10.1101/2021.01.27.21250612
Gabriel Chodick
1Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv Israel
2Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel
Lilac Tene
1Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv Israel
Tal Patalon
1Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv Israel
Sivan Gazit
1Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv Israel
Amir Ben Tov
1Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv Israel
Dani Cohen
2Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel
Khitam Muhsen
2Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel

Data Availability
Data cannot be shared due to regulatory limitations
Posted January 29, 2021.
The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
Gabriel Chodick, Lilac Tene, Tal Patalon, Sivan Gazit, Amir Ben Tov, Dani Cohen, Khitam Muhsen
medRxiv 2021.01.27.21250612; doi: https://doi.org/10.1101/2021.01.27.21250612
The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
Gabriel Chodick, Lilac Tene, Tal Patalon, Sivan Gazit, Amir Ben Tov, Dani Cohen, Khitam Muhsen
medRxiv 2021.01.27.21250612; doi: https://doi.org/10.1101/2021.01.27.21250612
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (500)
- Anesthesia (110)
- Cardiovascular Medicine (1230)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10005)
- Gastroenterology (497)
- Genetic and Genomic Medicine (2445)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1635)
- Health Policy (751)
- Hematology (248)
- HIV/AIDS (531)
- Medical Education (251)
- Medical Ethics (74)
- Nephrology (267)
- Neurology (2273)
- Nursing (139)
- Nutrition (349)
- Oncology (1244)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (154)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4824)
- Radiology and Imaging (833)
- Respiratory Medicine (650)
- Rheumatology (283)
- Sports Medicine (225)
- Surgery (266)
- Toxicology (44)
- Transplantation (124)
- Urology (99)